Home › Idiopathic Thrombocytopenic Purpura › New Jersey
Pag-aaral pangklinika para sa Idiopathic Thrombocytopenic Purpura sa New Jersey
4 pag-aaral para sa Idiopathic Thrombocytopenic Purpura ang naghahanap ng mga kalahok sa mga site sa New Jersey.
Opisyal na teksto ng pag-aaral (English)
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
- Astera Cancer Center, East Brunswick
- Summit Medical Group, Summit
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07421167A Study of Patients' Preferences for Primary Immune Thrombocytopenia Treatment
- Novartis, East Hanover
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07786077A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- American Oncology Partners of Maryland, PA, Morristown
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06948318A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- Regional Cancer Care Associates, LLC (RCCA), Little Silver
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 1, 2026 · NCT06544499Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.